How Rare Cannabinoids Will Impact Investing

There has been an explosion of interest in THCV recently, as well as a number of other uncommon cannabinoids. There will be big winners and losers in rare cannabinoid markets, but at the end of the day, the highest quality and lowest cost producers will capture most of these markets.

The post How Rare Cannabinoids Will Impact Investing appeared first on Cannabis Industry Journal.

Jazz Pharmaceuticals to Acquire GW Pharma

In a press release published last week, the two companies announced they have entered an agreement for Jazz to acquire GW Pharma, the producer of the only FDA-approved CBD medication Epidiolex, for a total of $7.2 billion.

The post Jazz Pharmaceuticals to Acquire GW Pharma appeared first on Cannabis Industry Journal.